Heart failure: the pivotal role of histone deacetylases

Area of Science:

• Cardiovascular Biology
• Epigenetics
• Molecular Medicine

Background:

• Heart failure presents a significant health burden with high mortality rates.
• Cardiac hypertrophy, characterized by increased cardiomyocyte size, contributes to heart failure progression and increases morbidity.
• Histone deacetylases (HDACs) are chromatin modifiers implicated in cardiac pathologies associated with hypertrophy.

Purpose of the Study:

• To explore the role of histone deacetylases in cardiac hypertrophy.
• To identify histone deacetylases as potential therapeutic targets for heart failure.

Main Methods:

• Review of literature on histone deacetylase function and cardiac pathology.
• Classification of histone deacetylases into four classes based on structure and function.
• Analysis of the pro-hypertrophic (Class I) and anti-hypertrophic (Class IIa) roles of specific HDACs.

Main Results:

• Histone deacetylases are crucial chromatin modifiers involved in cardiac hypertrophy.
• Class I HDACs are pro-hypertrophic, interacting with heat shock proteins.
• Class IIa HDACs are anti-hypertrophic, inhibiting transcription factors like myocyte enhancer factor 2.

Conclusions:

• Histone deacetylases represent a promising therapeutic target for managing cardiac hypertrophy.
• Targeting specific histone deacetylase classes may offer novel strategies to combat heart failure progression.